PKCα mediated induction of miR-101 in human hepatoma HepG2 cells

被引:43
|
作者
Chiang, Chao-Wei [1 ]
Huang, Yi [2 ]
Leong, Ka-Wai [2 ]
Chen, Lih-Chyang [3 ]
Chen, Hua-Chien [4 ]
Chen, Shu-Jen [4 ]
Chou, Chen-Kung [1 ,2 ]
机构
[1] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan
[2] Chang Gung Univ, Grad Inst Basic Med Sci, Dept Life Sci, Tao Yuan, Taiwan
[3] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Tao Yuan, Taiwan
[4] Chang Gung Univ, Mol Med Res Ctr, Genom Core Lab, Tao Yuan, Taiwan
关键词
PROTEIN-KINASE-C; HEPATOCELLULAR-CARCINOMA; GROWTH-INHIBITION; EPITHELIAL-CELLS; TUMOR-SUPPRESSOR; CANCER; MICRORNA-101; ACTIVATION; EXPRESSION; MECHANISM;
D O I
10.1186/1423-0127-17-35
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Protein Kinase C (PKC) is a serine/threonine kinase that involved in controlling of many cellular processes such as cell proliferation and differentiation. We have observed previously that TPA (12-O-tetradecanoylphorbol 13-acetate) induces cell cycle arrest in G0/G1 phase in human hepatoma HepG2 cells. However, is there any miRNA involved in PKCa mediated cell growth arrest is still unknown. Methods: We first surveyed 270 miRNA expression profiles in 20 pairs of human hepatoma tissues. We identified 11 up-regulated and 23 down-regulated miRNAs (FDR < = 0.01; fold-change > = 2) in human hepatoma tissue after Student's T-test and Mann-Whitney rank test. We then examined miRNAs expression profile in TPA treated HepG2 cells. Two miRNAs, miR-101, and miR-29c, were shown to be significantly down regulated in human hepatoma tissues and induced over 4-fold in HepG2 cells under TPA treatment. Results: In this study, we examined TPA regulated miRNA expression profile in human hepatoma HepG2 cells. We identified two miRNAs, 101 and 29c, were induced by TPA and down regulated in human hepatoma tissues suggest that they might play as tumor suppressor gene and in tumor formation of HCC. Since induction kinetics of miR-101 by TPA was much faster than miR-29c suggests that the induction of miR-101 may be the primary response of TPA treatment. We then further investigated how miR-101 was regulated by TPA. MiR-101 targets two subunits of PRC2 complex, enhancer of zeste homolog 2 (EZH2) and EED, and was shown to play as a tumor suppressor gene in human prostate, breast and liver cancers. The target sequence of miR-101 located in the 3' UTR of both EZH2 and EED's mRNA was identified by bioinformatic analysis and was validated by reporter luciferase activity assay. Then we showed that TPA not only up regulated miR-101 expression, but also reduced protein level of EZH2, EED and H3K27me3 in HepG2 cells. Using lenti-virus-mediated shRNA to knockdown endogenous PKCa expression, we observed that TPA induced growth arrest, elevation of miR-101 and reduction of EZH2, EED and H3K27me3 proteins were all PKCa dependent. Specific inhibitor of ERK completely blocked TPA induced miR-101 expression. Conclusions: Therefore, this is the first time to show that PKCa and ERK pathway play important role to activate miR-101 expression, reduce PRC2 complex and H3K27me3 level. This epigenetic regulatory pathway may represent a novel mechanism of carcinogenesis and deserve further investigation.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Lentivirus-mediated Silencing of Rhomboid Domain Containing 1 Suppresses Tumor Growth and Induces Apoptosis in Hepatoma HepG2 Cells
    Liu, Xue-Ni
    Tang, Zheng-Hao
    Zhang, Yi
    Pan, Qing-Chun
    Chen, Xiao-Hua
    Yu, Yong-Sheng
    Zang, Guo-Qing
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (01) : 5 - 9
  • [42] The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells
    Cheng, Jun
    Zhou, Lin
    Xie, Qin-Fen
    Xie, Hai-Yang
    Wei, Xu-Yong
    Gao, Feng
    Xing, Chun-Yang
    Xu, Xiao
    Li, Lan-Juan
    Zheng, Shu-Sen
    PROTEOMICS, 2010, 10 (08) : 1557 - 1572
  • [43] Enhanced Antitumor Effects of Adenoviral-Mediated siRNA against GRP78 Gene on Adenosine-Induced Apoptosis in Human Hepatoma HepG2 Cells
    Wu, Ling-Fei
    Guo, Yi-Tian
    Zhang, Qing-Hua
    Xiang, Meng-Qi
    Deng, Wei
    Ye, Yan-Qing
    Pu, Ze-Jin
    Feng, Jia-Lin
    Huang, Guan-You
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (01): : 525 - 544
  • [44] MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells
    Zheng, Shun-Zhen
    Sun, Ping
    Wang, Man-Ping
    Liu, Yong
    Gong, Wei
    Liu, Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (22) : 2752 - 2762
  • [45] Induction of mnsod gene by arachidonic acid is mediated by reactive oxygen species and p38 MAPK signaling pathway in human HepG2 hepatoma cells
    Bianchi, A
    Bécuwe, P
    Franck, P
    Dauça, M
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (11) : 1132 - 1142
  • [46] Effect of silencing NEK2 on biological behaviors of HepG2 in human hepatoma cells and MAPK signal pathway
    Zhang, Mei-Xia
    Xu, Xi-Ming
    Zhang, Peng
    Han, Na-Na
    Deng, Jun-Jian
    Yu, Ting-Ting
    Gan, Yuan-Yuan
    He, Xiao-Qin
    Long, Zhi-Xiong
    TUMOR BIOLOGY, 2016, 37 (02) : 2023 - 2035
  • [47] Pharmacological induction of leukotriene B4-12-hydroxydehydrogenase suppresses the oncogenic transformation of human hepatoma HepG2 cells
    Wei, Lai
    Liu, Jie
    Le, X. Chris
    Han, Yifan
    Tong, Yao
    Lau, Allan S. Y.
    Rong, Jianhui
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (03) : 735 - 745
  • [48] PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2
    Hu, Chi-Tan
    Cheng, Chuan-Chu
    Pan, Siou-Mei
    Wu, Jia-Ru
    Wu, Wen-Sheng
    CELLULAR SIGNALLING, 2013, 25 (06) : 1457 - 1467
  • [49] Tuning of apoptosis-mediator gene transcription in HepG2 human hepatoma cells through an adenosine signal
    Yang, Dongqin
    Yaguchi, Takahiro
    Lim, Chun-Ren
    Ishizawa, Youhei
    Nakano, Takashi
    Nishizaki, Tomoyuki
    CANCER LETTERS, 2010, 291 (02) : 225 - 229
  • [50] Ameliorative Effect of Posidonia oceanica on High Glucose-Related Stress in Human Hepatoma HepG2 Cells
    Vasarri, Marzia
    Barletta, Emanuela
    Stio, Maria
    Bergonzi, Maria Camilla
    Galli, Andrea
    Degl'Innocenti, Donatella
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)